These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29270434)

  • 41. Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
    Lu Y; Feng Y; Li Z; Li J; Zhang H; Hu X; Jiang W; Shi T; Wang Z
    Eur J Med Chem; 2022 Jan; 227():113908. PubMed ID: 34656900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.
    Mu L; Wang T; Chen Y; Tang X; Yuan Y; Zhao Y
    Int J Oncol; 2016 Oct; 49(4):1427-36. PubMed ID: 27498706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
    Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
    SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caffeine Effect on HIFs/VEGF Pathway in Human Glioblastoma Cells Exposed to Hypoxia.
    Maugeri G; D'Amico AG; Rasà DM; Saccone S; Federico C; Magro G; Cavallaro S; D'Agata V
    Anticancer Agents Med Chem; 2018; 18(10):1432-1439. PubMed ID: 29424319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TP3, an antimicrobial peptide, inhibits infiltration and motility of glioblastoma cells via modulating the tumor microenvironment.
    Chen YF; Shih PC; Kuo HM; Yang SN; Lin YY; Chen WF; Tzou SJ; Liu HT; Chen NF
    Cancer Med; 2020 Jun; 9(11):3918-3931. PubMed ID: 32266797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fabrication of 3D calcium-alginate scaffolds for human glioblastoma modeling and anticancer drug response evaluation.
    Chaicharoenaudomrung N; Kunhorm P; Promjantuek W; Heebkaew N; Rujanapun N; Noisa P
    J Cell Physiol; 2019 Nov; 234(11):20085-20097. PubMed ID: 30945284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
    Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
    Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
    Batchelor TT; Duda DG; di Tomaso E; Ancukiewicz M; Plotkin SR; Gerstner E; Eichler AF; Drappatz J; Hochberg FH; Benner T; Louis DN; Cohen KS; Chea H; Exarhopoulos A; Loeffler JS; Moses MA; Ivy P; Sorensen AG; Wen PY; Jain RK
    J Clin Oncol; 2010 Jun; 28(17):2817-23. PubMed ID: 20458050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
    Luo D; Fraga-Lauhirat M; Millings J; Ho C; Villarreal EM; Fletchinger TC; Bonfiglio JV; Mata L; Nemesure MD; Bartels LE; Wang R; Rigas B; Mackenzie GG
    Carcinogenesis; 2019 Dec; 40(12):1480-1491. PubMed ID: 30994173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-resolution tomographic analysis of in vitro 3D glioblastoma tumor model under long-term drug treatment.
    Ozturk MS; Lee VK; Zou H; Friedel RH; Intes X; Dai G
    Sci Adv; 2020 Mar; 6(10):eaay7513. PubMed ID: 32181351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
    Liu YC; Lee IC; Chen PY
    J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticancer effects of FL34 through the inhibition of GLI1 in glioblastoma.
    Li Y; Tang K; Huang L; Liu C; Du Q; Li T; Yan C; Feng Z; Li X
    J Cancer Res Ther; 2019; 15(4):889-898. PubMed ID: 31436248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384.
    Zhu Y; Shah K
    Cancer Biol Ther; 2014 Jun; 15(6):815-22. PubMed ID: 24658109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway.
    Chen C; Cheng CD; Wu H; Wang ZW; Wang L; Jiang ZR; Wang AL; Hu C; Dong YF; Niu WX; Qi S; Qi ZP; Liu J; Wang WC; Niu CS; Liu QS
    Acta Pharmacol Sin; 2021 Jan; 42(1):108-114. PubMed ID: 32398685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-tumor effects of progesterone in human glioblastoma multiforme: role of PI3K/Akt/mTOR signaling.
    Atif F; Yousuf S; Stein DG
    J Steroid Biochem Mol Biol; 2015 Feb; 146():62-73. PubMed ID: 24787660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-content imaging assays on a miniaturized 3D cell culture platform.
    Joshi P; Datar A; Yu KN; Kang SY; Lee MY
    Toxicol In Vitro; 2018 Aug; 50():147-159. PubMed ID: 29501531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coaxial extrusion bioprinted shell-core hydrogel microfibers mimic glioma microenvironment and enhance the drug resistance of cancer cells.
    Wang X; Li X; Dai X; Zhang X; Zhang J; Xu T; Lan Q
    Colloids Surf B Biointerfaces; 2018 Nov; 171():291-299. PubMed ID: 30048904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.